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ABSTRACT  
   
Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is widely 
accepted as the world's most abundant enzyme and represents the primary entry 
point for inorganic carbon into the biosphere. Rubisco's slow carboxylation rate of 
ribulose-1,5-bisphosphate (RuBP) and its susceptibility to inhibition has led some 
to term it the "bottle neck" of photosynthesis. In order to ensure that Rubisco 
remains uninhibited, plants require the catalytic chaperone Rubisco activase. 
Activase is a member of the AAA+ superfamily, ATPases associated with various 
cellular activities, and uses ATP hydrolysis as the driving force behind a 
conformational movement that returns activity to inhibited Rubisco active sites. A 
high resolution activase structure will be an essential tool for examining 
Rubisco/activase interactions as well as understanding the activase self-
association phenomenon. Rubisco activase has long eluded crystallization, likely 
due to its infamous self-association (polydispersity). Therefore, a limited 
proteolysis approach was taken to identify soluble activase subdomains as 
potential crystallization targets. This process involves using proteolytic enzymes 
to cleave a protein into a few pieces and has previously proven successful in 
identifying crystallizable protein fragments. Limited proteolysis, utilizing two 
different proteolytic enzymes (α-chymotrypsin and trypsin), identified two 
tobacco activase products. The fragments that were identified appear to represent 
most of what is considered to be the AAA+ C-terminal all α-domain and some of 
the AAA+ N-terminal αβα-domain. Identified fragments were cloned using the 
pET151/dTOPO. The project then moved towards cloning and recombinant 
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protein expression in E. coli. NtAβ(248-383) and NtAβ(253-354) were successfully 
cloned, expressed, purified, and characterized through various biophysical 
techniques. A thermofluor assay of NtAβ(248-383) revealed a melting temperature of 
about 30°C, indicating lower thermal stability compared with full-length activase 
at 43°C. Size exclusion chromatography suggested that NtAβ(248-383) is 
monomeric. Circular dichroism was used to identify the secondary structure; a 
plurality of α-helices. NtAβ(248-383) and NtAβ(253-354) were subjected to 
crystallization trials. 
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Through a process called photosynthesis, plants along with photosynthetic 
microorganisms utilize an electron donor, such as water, along with atmospheric 
carbon dioxide (CO2) to produce carbohydrates and oxygen (O2), using photons 
from sunlight as the energy source for the conversion. This highly complex 
natural event is what drives life on earth. Photosynthesis is undoubtedly 
influential in our daily lives as nearly every aspect of life as we know it can be 
related in some way or another to photosynthesis or its products. The products of 
photosynthesis are a large part of why there is human life on the planet.  
         
     
                
The oxygen product of photosynthesis is the key to aerobic life. Along 
with the different forms of energy that photosynthetic organisms provide for 
themselves, some photosynthetic organisms such as plants that produce fruits and 
vegetables are sources of energy not only for humans, but also a source of energy 
for many animals and other organisms. Photosynthesis has evolved over millions 
of years to what it is today. While current global food production is sufficient, 
there will be more people on Earth in the future, which will require more food, 
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1.2 Rubisco 
Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is the most 
abundant protein on earth and the main carbon fixing enzyme active during 
photosynthesis.
2
 It is responsible for adding inorganic CO2 to the sugar phosphate, 
ribulose-1,5-bisphosphate (RuBP). Rubisco’s catalytic reaction turns one 
molecule of RuBP into a product of two molecules of 3-phosphoglycerate 
(3PGA), which can be reformed into biomass by metabolism in the organism.  
The catalytic efficiency of Rubisco is dependent upon several factors. 
First, Rubisco requires ordered carbamylation of its large subunit lysine 201 
residue in conjunction with coordination of a Mg
2+ 
ion for activation of its active 
site.
3
 The CO2 added to Rubisco’s lysine 201 is not the same CO2 that is added to 
the RuBP during catalysis, it requires CO2 as a cofactor and a substrate. Without 
the carbamylated lysine residue in Rubisco’s active site, RuBP can bind tightly 
completely halting enzymatic activity in that particular site.
4 
Another factor 
affecting the catalytic efficiency of Rubisco is the competition of the oxygenation 
reaction of RuBP by Rubisco. Rubisco is capable of performing either 
carboxylation or oxygenation of its substrate RuBP.  
        
       
                            
        
       
                                                
Rubisco’s carboxylation reaction is favored to oxygenation despite O2 
being 25 times more prevalent in solution than CO2 at 25 C.
5
 The carboxylation 
product of RuBP is 2 molecules of 3PGA. The oxygenation of RuBP effectively 
reduces the amount of 3PGA produced during each reaction to half. This is 
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because the products of the oxygenation of RuBP are 1 molecule of 3PGA and 1 
molecule of 2-phosphoglycolate. Production of 2-phosphoglycolate does not 
require CO2 from the atmosphere and 2-phosphoglycolate is not used by plants to 
create biomass. Instead, 2-phosphoglycolate must be converted into a usable 
molecule through a process that requires energy in the form of adenosine 
triphosphate (ATP).  
Rubisco has been identified as the bottleneck of photosynthesis with a 




 For this reason, Rubisco has long been  investigated 
in the study of carbon fixation and crop improvement.
9
 
1.3 Rubisco Activase 
In the earlier work of Salvucci et al.
8
 a protein was discovered that is 
required to keep the active sites of Rubisco free from inhibitors. This protein uses 
energy from ATP hydrolysis as the driving force behind a relative movement, 
which is responsible for removing tightly bound inhibitors such as 2-
carboxyarabinatol-1,5-bisphosphate from the active site of Rubisco.
10,11
 This 
protein was termed ribulose-1,5-bisphosphate carboxylase/oxygenase activase or 
more simply, activase.
11,12
 In this sense, activase is indirectly responsible for 
photosynthesis regulation. Once activase was discovered to be essential to 
Rubisco’s activity, it became important to investigate activase as a means of 
increasing the efficiency of carbon fixation in plants. 
Amino acid sequence comparisons lead to the discovery that activase was 
part of a family of P-loop NTPases and belongs to the subclass of proteins called 
AAA+, which is short for ATPases associated with a variety of cellular 
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activities.
13, 14
 This family of P-loop NTPases has two highly conserved sequence 
motifs known as the Walker A and the Walker B motifs. The Walker A motif 
consists of GXXXXGKT/S and it coordinates the β-phosphate on the NTP. The 
Walker B motif consists of four hydrophobic residues followed by an aspartic 
acid or glutamic acid, which coordinates the γ-phosphate on the NTP.15 Other 
important features present on AAA+ proteins are slightly conserved Box regions 
and Sensor regions. The Box and Sensor regions are less conserved between 
proteins than the Walker motifs; however, the Sensor 2 region is exceptionally 
important because it contains two specific amino acids shown to correlate to the 
species specificity recognition site of activase.
16
 
When this project was started, crystallization of full-length activase had 
been unsuccessful, likely due to its propensity for polydispersity. This is one 
reason that limited proteolysis was an appealing technique for the investigation of 
the structure of activase. It is possible that truncated variants of activase are less 
likely to oligomerize if they are missing the specific amino acids needed for 
intermolecular interactions. Limited proteolysis has been used previously to cut 
proteins into fragments of proteins and to identify domain structure.
17, 18
 Limited 
proteolysis has also been used to make crystallizable fragments from full-length 
proteins with success by Botos et al.
19
  They were able to adjust the limited 
proteolysis conditions to isolate soluble stable fragments of the E. coli Lon 
protease. Then, they separated and crystallized the fragments, obtaining crystals 
that were able to diffract to a resolution of 1.9 Ǻ and ultimately solved the 
structure of that fragment. 
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At the beginning of this project there were no structures in the protein data 
bank (PDB) that had a high sequence homology to activase, this is not an 
uncommon occurrence with AAA+ proteins. For example, the AAA+ proteins 
HsLU and FtsH have low sequence homology; however, both proteins’ structures 
have been solved by X-ray crystallography, revealing a very similar fold. They 
both have an αβα region, connected by a short linker region to an all α region. It is 
for this reason that a homology model of activase, based on the structure of 
HsLU, was suspected to be fairly accurate. Since activase is a AAA+ protein, it is 
thought to have a similar structure to other AAA+ proteins even if the ultimate 
function differs.
20
 Due to the aforementioned reasons, a homology model of 
activase, provided by Archie Portis (USDA-ARS, U. of Illinois, Emeritus), is 
occasionally referred to when designing recombinant proteins. 
Since the initiation of this project, two important structural papers of 
higher plant Rubisco activase were published. The first paper, published by 
Henderson et al.
21
 was the X-ray structure of a recombinant protein fragment of 
activase from the creosote plant. This fragment consists of 97 amino acid residues 
that represent the majority of the all α-domain. The largely C-terminus structure 
consists of four helices, as expected, from a protein in the AAA+ superfamily; 
however, it contains a unique elongated helix number three. This long helix 
contains two amino acids that are responsible for the species specificity of 
activase.
16,22
 Species specificity is crucial because activase from the family of 
non-Solanaceae plants such as spinach is not capable of activating Rubisco from 
the family of Solanaceae such as tobacco and vice versa. The unique long helix 
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structure could be an artifact from crystallization or possibly an important feature 
for in vivo interactions with Rubisco.  
A German group also published a structural paper of higher plant Rubisco 
activase. Stotz et al.
23
 built a 293 amino acid long model of activase representing 
the majority of the activase protein. Stotz’s model has the C-terminus truncated 
by 23 amino acids and the N-terminus missing 67 amino acids. Their larger, yet 
still truncated, tobacco activase structure shows a C-terminal α domain that differs 
from the classical AAA+ fold. Their C-terminal domain contains a small, fifth 
helix about 1.5 turns in length. Stotz showed by mutagenesis that this small helix 




Currently, there are at least 1 billion chronically malnourished people 
around the world. With the world population increasing as it is, it is expected that 
by 2030 food production will need to be increased by 50%, and by 2050, food 
production will need to be twice as high as it is now.
24
 This creates pressure on 
the agricultural community to rapidly increase their production of food goods. In 
order to increase the amount of food from crops, there needs to be either more 
crops planted and harvested or the yield of crop per plant needs to be increased. 
Selecting for high yielding crops by planting seeds from the most productive 
plants has been successful in the past
25
; however, to increase crop yield by 100% 
of the current yield within 40 years is a challenge that will require the help of 
science. The challenge is not only that there will need to be such an incredibly 
large increase of available food goods, but also that over the next century the 
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average global temperature is expected to increase 2-4 °C. In certain areas such as 
Canada, the temperature is expected to increase 3-10 °C due to green house gases 
in the atmosphere.
26
 Global temperature increases can cause the entire world 
crops’ photosynthesis to be operating in temperatures that are, more frequently, 
above optimal for photosynthesis. It is possible that plants will be able to 
acclimate to the increase in temperatures naturally; however, it is also possible 




Since Rubisco has been identified as the bottle neck of photosynthesis, it 
follows that it should be investigated as a means of increasing future crop yields. 
In order to make Rubisco a more efficient enzyme, all of its activities will need to 
be investigated thoroughly. Rubisco activase interacts directly with Rubisco. At 
the start of this thesis project the structure of activase was unknown as well as the 
specific physical interactions between Rubisco and activase. Identifying the 
structure will allow the specific interactions to be investigated further.
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CHAPTER 2 
EXPERIMENTAL SECTION 
2.1 Recombinant Protein (NtAβ(248-383)), Design Based on Homology Model 
2.1.1 NtAβ(248-383) Recombinant Protein Cloning 
Polymerase chain reaction (PCR) primers were ordered from Integrated 
DNA Technologies to amplify part of a DNA sequence. The amplified sequence 
coded for a 136 amino acid long protein, creating an N-terminal truncated variant 
of Nicotiana tabacum (tobacco) Rubisco activase. The forward primer utilized for 
this experiment was 5’-CAC CTT CTA CTG GGC ACC AAC-3’. The reverse 
primer used was 5'-CTA ACT AGC AAA GAA GGA TCC ATT G-3'. The PCR 
was performed using the previously mentioned primers along with a pET23a(+) 
plasmid containing a gene that coded for full-length tobacco activase protein. The 
PCR product was confirmed to be present and purified, using agarose gel 
electrophoresis. The PCR product was removed from agarose gel, using a Qiagen 
gel extraction kit. TOPO cloning of the PCR product into the pET151/dTOPO 
vector was performed according to the directions of Invitrogen’s Champion pET 
Directional TOPO Expression Kit. TOP10 cells were then transformed with the 
pET151/dTOPO vector using heat shock and spread onto a carbenicillin 
supplemented (100 mg/mL carbenicillin) agar plate and allowed to grow at 37°C 
for 12 hours. 6 colonies were subsequently selected and allowed to grow in 25 ml 
of Lysogeny Broth (LB) media. The resulting plasmids were then extracted from 
each of the 6 samples of cells using a Qiagen spin miniprep kit. Samples of each 
plasmid were taken to the ASU DNA facility to be sequenced and the 
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concentrations of plasmid were determined using a NanoDrop 1000 
spectrophotometer. 
2.1.2 NtAβ(248-383) Recombinant Protein Expression 
The initial step of protein expression involves transformation of 
BL21*(DE3) cells. For the transformation, 50 μl of BL21*(DE3) cells were put 
into an Eppendorf tube on ice. Then, 0.5 μl of plasmid, identified by the ASU 
sequencing facility to contain the gene of interest, was added to the cells, mixed 
by stirring with a pipette tip, and let sit on ice for 30 minutes. The cells were 
subsequently heat shocked for 45 seconds at 42°C, then placed on ice for 2 
minutes. Next, 0.5 ml of SOC was added to the cells in the Eppendorf tube and 
the cells were placed into an incubator/shaker for 1 hour at 37°C with a rotation 
rate of 250 rpm. After 1 hour, 100 μl of cell growth was plated onto a 
carbenicillin supplemented (100 mg/mL carbenicillin) LB agar plate and 
incubated at 37°C overnight. The following day, using sterile technique, 4 of the 
colonies were picked and put into 4 separate culture tubes, containing 25 ml of 
LB supplemented with carbenicillin (100 mg/mL carbenicillin) and allowed to 
grow overnight in an incubator/shaker at 37°C and 250 rpm.  Following this, four 
1 L LB cultures were created by inoculating each 1 L of LB supplemented with 
carbenicillin (100 mg/mL carbenicillin) using the 4 previously created 25 ml 
“overnight” cultures. The 1 L cultures were allowed to grow in the 
incubator/shaker at 37°C and 250 rpm until an optical density (OD) of 0.6 at 600 
nm was reached. The cultures were then cooled to 18°C and protein production 
was induced by adding isopropyl β-D-1-thiogalactopyranoside to a 1 mM final 
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concentration. Cultures were placed back into the incubator/shaker with the 
temperature set to 18°C and rotations set at 200 rpm for 16 hours. 
2.1.3 NtAβ(248-383) Recombinant Protein Purification 
Cells were harvested by centrifugation and frozen at -80°C. To purify the 
protein, the cell pellet was suspended in lysis buffer consisting of 50 mM HEPES 
pH 8.0, 0.3 M KCL,10% glycerol, 1 mM DTT, 20 mM imidazole at pH 8.0 and 
0.1% Triton X-100 and sonicated. The mixture was then centrifuged and the 
supernatant was harvested. The supernatant was then filtered through a 0.8 μm 
syringe filter. The filtered supernatant was loaded onto a 5 ml total volume nickel 
column (GE Healthcare) and eluted fractions were collected. The first wash was 
with 20 mM imidazole. The protein was then eluted with a 200 mM imidazole 
wash. The final wash was with 500 mM imidazole to clean any residual material 
off the column. A quick Bradford assay of all eluent was performed to confirm 
the presence of protein in the fractions where the protein was expected to elute. 
The proper protein factions were pooled, and the histidine tag was removed using 
a his-tagged tobacco etch virus (TEV) protease while being dialyzed overnight in 
order to remove the imidazole to allow for further purification. Next, the mixture 
was loaded onto a 5 ml volume nickel (GE Healthcare) column. The protein 
eluted in the flow through and with the first 20 mM imidazole wash. The protein 
was then concentrated to 18.6 mg ml
-1
 using a Millipore amicon ultra, ultracel 10 
kDa centrifugal concentrator. A Bradford assay was performed in triplicate to 
determine the concentration of protein. The protein was then flash frozen in liquid 
nitrogen and stored at -80°C for future use. 
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2.1.4 NtAβ(248-383) Recombinant Protein Characterization 
Size exclusion chromatography was used to investigate the polydispersity 
of the Recombinant Protein NtAβ(248-383). Size exclusion chromatography 
experiments were performed using a Waters 600S controller paired with a Waters 
996 detector HPLC and a Phenomonex Biosep 4000 column. 
A thermal denaturation thermofluor assay was performed using SYPRO 
Orange as the fluorescent dye.  The assay was performed in an Applied 
Biosystems real time PCR machine. The secondary structure of this fragment was 
investigated by circular dichroism (CD) using a Jasco 710 Spectropolarimeter. 
Data from the CD experiment was analyzed to investigate secondary structure 
using an unpublished deconvolution program created by James Zook from Dr. 
Petra Fromme’s lab. 
Crystallization screens were setup in a cold room at 10°C using the 
hanging drop vapor diffusion method.
27
 Both Hampton’s Index Screen and 
Crystal Screen Cryo were used. Each screen was setup using two different 
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2.2 Recombinant Protein (NtAβ(253-354)), Design Based on Crystallized 
Creosote Activase 
2.2.1 NtAβ(253-354) Recombinant Protein Cloning 
Polymerase chain reaction (PCR) primers were ordered from Integrated 
DNA Technologies to amplify part of a DNA sequence. The amplified sequence 
coded for a 102 amino acid long protein, creating an N-terminal and C-terminal 
truncated variant of Nicotiana tabacum (tobacco) Rubisco activase. The forward 
primer utilized for this experiment was 5'-CAC CAG GGA AGA CAG AAT 
TGG-3'. The reverse primer used was 5'-TTA TCT CTT CAC ATT TTC TTG C-
3'. The PCR was performed using the previously mentioned primers along with a 
pET23a(+) plasmid containing a gene that coded for full-length tobacco activase 
protein. The PCR product was confirmed to be present using agarose gel 
electrophoresis. TOPO cloning of the PCR product into the pET151/dTOPO 
vector was performed according to the directions of the Invitrogen’s Champion 
pET Directional TOPO Expression Kit. TOP10 cells were then transformed with 
the pET151/dTOPO vector using heat shock and spread onto a carbenicillin 
supplemented (100 mg/mL carbenicillin) agar plate and allowed to grow at 37°C 
for 12 hours. Multiple colonies were subsequently selected and allowed to grow 
in 25 ml of LB media. The resulting plasmids were then extracted from the media 
using a Qiagen spin miniprep kit. Samples of each plasmid were taken to the ASU 
DNA facility to be sequenced and the concentrations of plasmid were determined 
using a NanoDrop 1000 spectrophotometer. 
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2.2.2 NtAβ(253-354) Recombinant Protein Expression 
The initial step involves transformation of BL21*(DE3) cells. For the 
transformation, 50 μl of BL21*(DE3) cells were put into an Eppendorf tube on 
ice. Then, 0.5 μl of plasmid, identified by the ASU sequencing facility to contain 
the gene of interest, was added to the cells, mixed by stirring with a pipette tip, 
and let sit on ice for 30 minutes. The cells were heat shocked for 45 seconds at 
42°C then placed on ice for 2 minutes. Next, 0.5 ml of SOC was added to the cells 
in the Eppendorf tube and the cells were placed into an incubator/shaker for 1 
hour at 37°C with a rotation rate of 250 rpm. After 1 hour, 100 μl of cell growth 
was plated onto a carbenicillin supplemented (100 mg/mL carbenicillin) LB agar 
plate and incubated at 37°C overnight. The following day, using sterile technique, 
4 of the colonies were picked and put into 4 separate culture tubes, containing 25 
ml of LB supplemented with carbenicillin (100 mg/mL carbenicillin) and allowed 
to grow overnight in an incubator/shaker at 37°C and 250 rpm.  Following this, 
four 1 L LB cultures were created by inoculating each 1 L of LB supplemented 
with carbenicillin (100 mg/mL carbenicillin) using the 4 previously created 25 ml 
“overnight” cultures. The 1 L cultures were allowed to grow in the 
incubator/shaker at 37°C and 250 rpm until an optical density (OD) of 0.6 at 600 
nm was reached. Next, protein production was induced by adding isopropyl β-D-
1-thiogalactopyranoside to a 1 mM final concentration. Cultures were placed back 
into the incubator/shaker with the temperature set to 30°C and rotations set at 200 
rpm for 14 hours. 
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2.2.3 NtAβ(253-354) Recombinant Protein Purification 
Cells were harvested by centrifugation and frozen at -80°C. To purify the 
protein, the cell pellet was suspended in lysis buffer consisting of 50 mM HEPES 
pH 8.0, 0.3 M KCL,10% glycerol, 1 mM DTT, 20 mM imidazole at pH 8.0, and 
0.1% Triton X-100 and sonicated. The mixture was then centrifuged and the 
supernatant was harvested. The supernatant was then filtered through a 0.8 μm 
syringe filter. The filtered supernatant was loaded onto a 5 ml nickel column 
(Qiagen Ni-NTA superflow) and eluted fractions were collected. The first wash 
was with 50 mM imidazole. The next wash was with 100 mM imidazole where a 
large amount of the protein was eluted. The final wash was with 500 mM 
imidazole to clean any residual material off the column. A quick Bradford assay 
was performed to confirm the presence of protein in the fractions where the 
protein was expected to elute. The proper protein factions were pooled, and the 
histidine tag was then removed by a his-tagged tobacco etch virus (TEV) protease 
while being dialyzed overnight to remove the imidazole to allow for further 
purification. Next, the mixture was loaded onto a 5 ml nickel column (Qiagen Ni-
NTA superflow). The protein eluted in the flow through and with a 20 mM 
imidazole wash. The protein was then concentrated and buffer exchanged into 10 
mM HEPES pH 7.0, 100 mM NaCl, and 0.04% NaN3 using a Millipore amicon 
ultra, ultracel 10 kDa centrifugal concentrator. Protein concentration was 
quantified using a NanoDrop 1000 spectrophotometer. 
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2.2.4 NtAβ(253-354) Recombinant Protein Characterization 
Using a Wyatt DynaPro NanoStar, a Dynamic light scattering experiment 
was performed on a 0.1 μm filtered, 5 mg/ml sample of NtAβ(253-354). 
96 well sitting-drop trays were set up using a Rigaku Phoenix-HT 
crystallization robot to screen NtAβ(253-354) with the protein concentration at 60 
mg/mL. Tested commercial screens from Hampton Research included:  Cryo 
screens 1 and 2 (96 conditions), Index screen (96 conditions) and Crystal screen 
(96 conditions). Upon set up, experimental trays were sealed and transferred to a 
4°C cold room. 
2.3 Limited Proteolysis and Design of Genetic Constructs 
2.3.1 Limited Proteolysis 
Limited proteolysis was performed on a 51 amino acid N-terminally 
truncated variant of tobacco Rubisco activase provided by Dr. Michael Salvucci 
from the US Department of Agriculture. The technique utilized two different 
proteolytic enzymes:  α-chymotrypsin (Sigma Aldrich, C4129) and trypsin 
(Sigma Aldrich, T8003). Reaction conditions were optimized first for α-
chymotrypsin, then for trypsin. The conditions that were optimized are as follows:  
the molar ratio of activase to proteolytic enzyme, time allowed for proteolytic 
enzyme activity, and the concentration of adenosine diphosphate (ADP). 
Conditions were optimized by observing products of the proteolysis, using 12% 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and 
adjusting the conditions as necessary.  
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The first conditions optimized were the molar ratio of activase to 
proteolytic enzyme and the time allowed for proteolysis. The limited proteolysis 
reactions (henceforth, referred to as digestions) were performed in 0.5M HEPES 
pH 7.9, at 26°C, with a constant concentration of 16.8 μM activase and 18.3 μM 
ADP in a total volume of 1 ml. The concentration of α-chymotrypsin was varied. 
Experimentation commenced with separate digestions utilizing molar ratios of 
activase to α-chymotrypsin of 233:1, 624:1, 6,247:1, 62,475:1 and 624,750:1. 
These ratios were created by adding specific volumes of a 0.018 mg ml
-1
 stock 
solution of α-chymotrypsin. The digestions were allowed to proceed for 2 hours 
(120 min) with samples of the digestions taken at 0 min, 30 min, 60 min, 90 min, 
and 120 min. Each sample was heated to 90°C for 10 minutes prior to being 
frozen at -20°C. After all samples were collected, they were analyzed via a 12% 
SDS-PAGE. 
To optimize the amount of ADP in the digestion, reactions were set up as 
follows:  0.5M HEPES pH 7.9 with a constant concentration of 16.8 μM activase 
and 7.2 x 10
-11
 M chymotrypsin. The concentration of ADP in the digestions was 
varied from 8.3 μM to 38.3 μM in 5 μM increments. This was done by adding 
specific volumes from a stock of 0.5 mM ADP.  
2.3.2 Limited Proteolysis Fragment Isolation 
A digestion was performed under optimized conditions (ratio of activase 
to α-chymotrypsin 233:1, 8.3μM ADP for 60 minutes). The digestion progression 
was quenched by the addition of phenylmethanesulfonylfluoride (PMSF). The 
digestion was prepared for analysis using a 0.8 μm syringe filter to remove any 
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possible large aggregation that may be present in the sample. The filtered sample 
was analyzed by reverse phase high performance liquid chromatography (RP-
HPLC) utilizing a reverse phase C18 column (Vydac 218TP45) attached to a 
Waters 600S controller paired with a Waters 996 detector. The mobile phase 
started as 100% A [water with 0.1% (v/v) trifluoroacetic acid (TFA)] and was 
transitioned to 70% B (acetonitrile) at a rate of 1% per minute. Absorbance was 
monitored at 220 nm and 280 nm.  
SDS gels to be used for electrophoretic protein transfer (blotting) were 
allowed to polymerize for 24 hours at room temperature to assure complete 
polymerization. Running buffer, used for SDS gels, to be used for blotting 
consisted of 1X Tris-Glycine-SDS (TGS) and 5.13 mg of sodium thioglycolate 
(reducing agent). Blotting was performed in a Bio-Rad tank transfer system. 
Transfer buffer was made using 3.03 g of Tris base and 14.4 g glycine in 200 ml 
of methanol with the addition of distilled, deionized water until a volume of 1 L 
was reached. Polyvinylidene fluoride (PVDF) membrane was immersed in 100% 
methanol for 60 seconds and then soaked in transfer buffer for 5 minutes to 
hydrate and facilitate protein transfer. Proteins were allowed to transfer for 75 
minutes at 350 mA constant current. The PVDF membrane was then stained with 
coomassie brilliant blue R-250 in a 40% methanol solution. De-staining solution 
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2.3.3 Limited Proteolysis Fragment Identification 
Several PVDF blot samples were taken to the ASU proteomics lab for N-
terminal sequencing with several analogous samples being saved for mass 
spectrometry. 
Mass spectrometry was performed using matrix-assisted laser 
desorption/ionization time of flight (MALDI TOF) on a Voyager-DE STR TOF. 
The samples were retained on the PVDF membrane. An aliquot of cytochrome-c 
was placed on the PVDF membrane next to the digest sample in order to have a 
baseline to correct for the thickness of the PVDF membrane. The matrix used was 
α-Cyano-4-hydroxycinnamic acid mixed in toluene and methanol. The 
measurements were obtained in linear positive mode. 
2.3.4 Recombinant Protein (NtAβ(182-383)) Based on Limited Proteolysis 
2.3.4.1 NtAβ(182-383) Recombinant Protein Cloning  
Polymerase chain reaction (PCR) primers were ordered from Integrated 
DNA Technologies to amplify part of a DNA sequence. The amplified sequence 
coded for a 202 amino acid long protein creating an N-terminal truncated variant 
of Nicotiana tabacum (tobacco) Rubisco activase. The forward primer utilized for 
this experiment was 5'-CAC CAT GGG CGG AAC TAC ACA ATA CAC-3'. The 
reverse primer used was 5'-CTA ACT AGC AAA GAA GGA TCC ATT GTT 
AAT G-3'. The PCR was performed using the previously mentioned primers 
along with a pET23a(+) plasmid containing a gene that coded for full-length 
tobacco activase protein. The PCR product was confirmed to be present using 
agarose gel electrophoresis. TOPO cloning of the PCR product into the 
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pET151/dTOPO vector was performed as according to the directions of 
Invitrogen’s Champion pET Directional TOPO Expression Kit. TOP10 cells were 
then transformed with the pET151/dTOPO vector using heat shock and spread 
onto a carbenicillin supplemented (100 mg/mL carbenicillin) agar plate and 
allowed to grow at 37°C for 12 hours. Multiple colonies were subsequently 
selected and allowed to grow in 25 ml of LB media. The resulting plasmids were 
then extracted from the media using a Qiagen spin miniprep kit. Samples of each 
plasmid were taken to the ASU DNA facility to be sequenced and the 
concentrations of plasmid were determined using a NanoDrop 1000 
spectrophotometer. 
2.3.4.2 NtAβ(182-383) Recombinant Protein Expression 
The initial step involves transformation of BL21*(DE3) cells. For the 
transformation, 50 μl of BL21*(DE3) cells were put into an Eppendorf tube on 
ice. Then, 0.5 μl of plasmid, identified by the ASU sequencing facility to contain 
the gene of interest, was added to the cells, mixed by stirring with a pipette tip, 
and let sit on ice for 30 minutes. The cells were heat shocked for 45 seconds at 
42°C then placed on ice for 2 minutes. Next, 0.5 ml of SOC was added to the cells 
in the Eppendorf tube and the cells were placed into an incubator/shaker for 1 
hour at 37°C with a rotation rate of 250 rpm. After 1 hour, 100 μl of cell growth 
was plated onto a carbenicillin supplemented (100 mg/mL carbenicillin) LB agar 
plate and incubated at 37°C overnight. The following day, using sterile technique, 
4 of the colonies were picked and put into 4 separate culture tubes, containing 25 
ml of LB supplemented with carbenicillin (100 mg/mL carbenicillin) and allowed 
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to grow overnight in an incubator/shaker at 37°C and 250 rpm.  Following this, 
four 1 L LB cultures were created by inoculating each 1 L of LB supplemented 
with carbenicillin (100 mg/mL carbenicillin) using the 4 previously created 25 ml 
“overnight” cultures. The 1 L cultures were allowed to grow in the 
incubator/shaker at 37°C and 250 rpm until an optical density (OD) of 0.6 at 600 
nm was reached. The cultures were then cooled to 25°C and protein production 
was induced by adding isopropyl β-D-1-thiogalactopyranoside to a 1 mM final 
concentration. Cultures were placed back into the incubator/shaker with the 
temperature set to 25°C and rotations set at 200 rpm for 16 hours. 
2.3.4.3 NtAβ(182-383) Recombinant Protein Purification 
Cells were harvested by centrifugation and frozen at -80°C. To purify the 
protein, the cell pellet was suspended in lysis buffer consisting of 50 mM HEPES 
pH 8.0, 0.3 M KCL,10% glycerol, 1 mM DTT, 20 mM imidazole at pH 8.0 and 
0.1% Triton X-100 and sonicated. The mixture was then centrifuged and the 
supernatant was harvested. The supernatant was then filtered through a 0.8 μm 
syringe filter. The filtered supernatant was loaded onto a 5 ml nickel column 
(Qiagen Ni-NTA superflow) and eluted fractions were collected. The first wash 
was with 20 mM imidazole. The protein was then eluted with a 200 mM 
imidazole wash. A final wash was performed with 500 mM imidazole. A quick 
Bradford assay was performed to try to confirm the presence of protein in the 
fractions where the protein was expected to elute. Purification for this protein 
stopped here because there was no protein present in the eluent. SDS-PAGE was 
performed which showed very little protein expression. 
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This experiment was repeated with expression temperatures of 30°C and 
37°C which was not found to help the expression levels. 
2.3.4.4 NtAβ(216-383) Recombinant Protein Cloning  
Polymerase chain reaction (PCR) primers were ordered from Integrated 
DNA Technologies to amplify part of a DNA sequence. The amplified sequence 
coded for a 168 amino acid long protein creating an N-terminal truncated variant 
of Nicotiana tabacum (tobacco) Rubisco activase. The forward primer utilized for 
this experiment was 5'-CAC CAA CAA ACA AGA GAA TGC CAG GG-3'. The 
reverse primer used was 5'-CTA ACT AGC AAA GAA GGA TCC ATT GTT 
AAT G-3'. The PCR was performed using the previously mentioned primers 
along with a pET23a(+) plasmid containing a gene that coded for full-length 
tobacco activase protein. The PCR product was confirmed to be present using 
agarose gel electrophoresis. TOPO cloning of the PCR product into the 
pET151/dTOPO vector was performed according to the directions of Invitrogen’s 
Champion pET Directional TOPO Expression Kit. TOP10 cells were then 
transformed with the pET151/dTOPO vector using heat shock and spread onto a 
carbenicillin supplemented (100 mg/mL carbenicillin) agar plate and allowed to 
grow at 37°C for 12 hours. Multiple colonies were subsequently selected and 
allowed to grow in 25 ml of LB media. The resulting plasmids were then 
extracted from the media using a Qiagen spin miniprep kit. Samples of each 
plasmid were taken to the ASU DNA facility to be sequenced and the 
concentrations of plasmid were determined using a NanoDrop 1000 
spectrophotometer. 
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2.3.4.5 NtAβ(216-383) Recombinant Protein Expression 
The initial step involves transformation of BL21*(DE3) cells. For the 
transformation, 50 μl of BL21*(DE3) cells were put into an Eppendorf tube on 
ice. Then, 0.5 μl of plasmid, identified by the ASU sequencing facility to contain 
the gene of interest, were added to the cells, mixed by stirring with a pipette tip, 
and let sit on ice for 30 minutes. The cells were heat shocked for 45 seconds at 
42°C then placed on ice for 2 minutes. Next, 0.5 ml of SOC was added to the cells 
in the Eppendorf tube and the cells were placed into an incubator/shaker for 1 
hour at 37°C with a rotation rate of 250 rpm. After 1 hour, 100 μl of cell growth 
was plated onto a carbenicillin supplemented (100 mg/mL carbenicillin) LB agar 
plate and incubated at 37°C overnight. The following day, using sterile technique, 
4 of the colonies were picked and put into 4 separate culture tubes, containing 25 
ml of LB supplemented with carbenicillin (100 mg/mL carbenicillin) and allowed 
to grow overnight in an incubator/shaker at 37°C and 250 rpm.  Following this, 
four 1 L LB cultures were created by inoculating each 1 L of LB supplemented 
with carbenicillin (100 mg/mL carbenicillin) using the 4 previously created 25 ml 
“overnight” cultures. The 1 L cultures were allowed to grow in the 
incubator/shaker at 37°C and 250 rpm until an optical density (OD) of 0.6 at 600 
nm was reached. The cultures were then cooled to 25°C and protein production 
was induced by adding isopropyl β-D-1-thiogalactopyranoside to a 1 mM final 
concentration. Cultures were placed back into the incubator/shaker with the 
temperature set to 25°C and rotations set at 250 rpm for 16 hours. 
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2.3.4.6 NtAβ(216-383) Recombinant Protein Purification 
Cells were harvested by centrifugation and frozen at -80°C. To purify the 
protein, the cell pellet was suspended in lysis buffer consisting of 50 mM HEPES 
pH 8.0, 0.3 M KCL,10% glycerol, 1 mM DTT, 20 mM imidazole at pH 8.0 and 
0.1% Triton X-100 and sonicated. The mixture was then centrifuged and the 
supernatant was harvested. The supernatant was then filtered through a 0.8 μm 
syringe filter. The filtered supernatant was loaded onto a 5 ml nickel column 
(Qiagen Ni-NTA superflow) and eluted fractions were collected. The first wash 
was with 20 mM imidazole. The protein was then eluted with a 200 mM 
imidazole wash. A final wash was performed with 500 mM imidazole. A quick 
Bradford assay was performed to try to confirm the presence of protein in the 
fractions where the protein was expected to elute. Purification for this protein 
stopped here because there was minimal protein present in the eluent. SDS-PAGE 
was performed which showed that the majority of the protein was in the pellet. 
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CHAPTER 3 
RESULTS, DISCUSSION, CONCLUSION, AND FUTURE WORK 
3.1 Results and Discussion 
3.1.1 NtAβ(248-383) Fragment Based on Homology Model 
NtAβ(248-383), a 136 amino acid long soluble protein fragment which was 
designed based on a homology model was successfully cloned into 
pET151/dTOPO. After expression 18.6 mg of protein from an 11.4 g cell pellet 
was obtained. The N-terminus of the recombinant protein that was created starts 
with the three aromatic amino acids, predicted to be near the hinge region, and 
ends at the full-length C-terminus. This fragment was selected to be cloned first 
instead of the limited proteolysis identified fragments because this fragment was 
predicted to be more stably folded based on the homology model than the 
fragments that were identified using limited proteolysis. The fragments identified 
by limited proteolysis are suspected to contain parts of both the αβα subdomain 
and the all α subdomain making them unlikely candidates to be stably folded.   
 Characterization of the recombinant protein involved determining its 
dispersity, melting temperature, and secondary structure. Its dispersity was 
investigated using size exclusion chromatography (SEC). Figure 1 below shows a 
chromatogram from full-length activase with broad, non-gaussian shaped bands. 
Figure 2 below shows the SEC data of the NtAβ(248-383) fragment. The Gaussian 
peak at about 26.5 minutes is the NtAβ(248-383) fragment. The curve from the 
NtAβ(248-383) is representative of a monodisperse protein having a single narrow 
peak and no trailing peak, whereas the curve from the full-length activase shows a 
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wide trailing peak. This wide trailing peak is actually several, smaller peaks 
following the first. These trailing peaks represent multiple assembly states present 
in the solution, hence the polydispersity. The retention time of the NtAβ(248-383) is 
typical for a monomeric protein of that size protein (15.3 kDa).  
 
Figure 1: SEC data of full-length activase, showing that retention time changes 
with concentration. Different multimers of full-length activase as indicated. 
Chromatogram courtesy of Alison Dunkle. 























Figure 2: SEC data from NtAβ(248-383) showing 220 nm and 280 nm absorbance. 
The 280 nm gaussian peak at 26.5 minutes is representative of a NtAβ(248-383) 
fragment in a single assembly state with a 15 kDa retention time. Chromatogram 
courtesy of Alison Dunkle. 
 
 A thermoflour assay was performed on the NtAβ(248-383) fragment. 
Thermofluor assays use a dye that has a low fluorescence quantum yield in 
hydrophilic environments and high fluorescence quantum yield in hydrophobic 
environments such as near the hydrophobic residues of a denatured protein.
28
 The 
thermofluor assay, as can be seen in Figure 3 below, shows the increase in 
fluorescence of the SYPRO Orange dye upon heat denaturation. The melting 
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temperature based on this assay was estimated to be around 30°C, which is 
relatively low compared to some of the more stable full-length activase species 
such as cotton or creosote activase, which melt at 39°C and 42°C respectively. In 
general the melting temperature is representative of the stability of the protein, the 
lower the melting temperature the less stable the protein. The low thermal 
stability is probably due to a large amount of disordered amino acids. An example 
of a stably folded protein is hen egg white lysozyme, which has a melting 
temperature of about 72°C.
29
 It is possible that more thermally stable proteins 




























Figure 3: Thermofluor assay of NtAβ(248-383) data shows changes in fluorescence 
as temperature of the fragment is increased. 
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 A circular dichroism (CD) experiment was performed on the NtAβ(248-383) 
fragment. Results can be seen below in Figure 4. The 15°C CD data was put 
through several deconvolution programs:  CDSSTR, SELCON3, and ContnII. The 
computer-calculated percent composition of α-helix, β-sheet, turn, and unordered 
regions were averaged. The plurality was α-helix with a composition of 34% α-
helix, the next highest was unordered regions at 30%, followed by turns at 19%, 
and lastly β-sheets at 15%. This data suggests that there is a large amount of 
unordered amino acids. This could mean that removing some of the N-terminal or 
C-terminal amino acids could result in the loss of some of the unordered amino 
acids and improvement of thermal stability. 
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Figure 4: 15°C CD data of NtAβ(248-383) shows results similar to an all α-helix 
secondary structure.  
 
 Two crystal screens were set up with different concentrations for the 
NtAβ(248-383) fragment. In the first Index and Cryo crystal screens that were setup, 
nearly all of the protein drops precipitated instantly. That was an indication that 
the concentration of the protein was likely too high. For the next trial, the screens 
were setup using 6.2 mg ml
-1
 instead of 18.6 mg ml
-1
. The number of drops that 
precipitated instantly decreased to about half. The screens were checked after 3 
days, then 6 days, then 2 weeks with only signs of phase separation—no crystals. 
It is possible that the amount of disordered protein is too large, thus preventing 
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crystal growth. In order for protein crystals to form, the proteins must adopt a 
compact fold. 
3.1.2 NtAβ(253-354) Based on Creosote Fragment 
 Dynamic light scattering (DLS) is a tool that can be used to estimate the 
sizes of various particles in a solution. DLS measures fluctuations of the average 
intensity of light being scattered by particles in solution, moving randomly 
through a focused laser beam. Globular proteins are assumed to be spherical in 
shape and that allows the use of the Stokes-Einstein relation to calculate the 
apparent hydrodynamic radius.
30
 The apparent hydrodynamic radius was 
calculated by the DLS software and the results can be seen below in Figure 5. The 
data shows that the DLS experiment on NtAβ(253-354) identified 97% of the 
particles in solution as particles with a size of about 46 kDa, likely a tetramer; 
however, particles with a mass of about 307,000 kDa scattered the majority of the 
light, roughly 52% of it. This is interesting because the sample was filtered with a 
0.1 μm filter, which means that the protein fragment must aggregate 
spontaneously. This experiment shows similar results to DLS experiments with 
Henderson’s creosote variant fragment in solution. 
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Figure 5: Dynamic Light Scattering results of NtAβ(253-354) show a large amount 
of small multimers of activase and a few large aggregates. 
 
While no crystals for NtAβ(253-354) have been observed to date, this protein 
is still under investigation. It was designed based on a successfully crystallized 
fragment of Rubisco activase from the creosote plant. Henderson et al. were able 
to clone, express, purify, and crystallize the substrate recognition domain of 
higher plant Rubisco activase.
21 
This fragment has the expected four helix bundle 
all α-domain; however, its helix number 3 is interestingly unique. Helix 3 extends 
outward further than was expected. Helix 3 of Henderson’s model is important 
because it contains amino the acids of the species specificity recognition domain. 
There have been two higher plant Rubisco activase structures published with 
different conformations for this specific helix. While Henderson’s structure has a 
roughly 9-turn helix, Stotz’s paper has a structure of the same helix with only 
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about 6 turns connected by a linker to a small helix of about 1.5 turns. Stotz’s 
small helix is the helix that contains the amino acids responsible for species 
specificity. It is possible that either structure is the physiological relevant 
structure. The only way to determine the purpose of the long helix and the 
physiologically relevant structure is by solving more activase structures and 
comparing them. Hopefully with a little more truncation or different 
crystallization parameters, the NtAβ(253-354) fragment will crystallize so that it can 
be compared to both the creosote structure and Stotz’s structure. The most recent 
paper by Stotz did not comment on the differences between his model’s helix 8 
and helix 9 and Henderson’s model’s equivalent helix 3. 
3.1.3 Limited Proteolysis 
A chart of the optimized conditions to obtain the maximum amount of 
limited proteolysis products can be seen below in Table 1. The molar ratio of 
proteolytic enzyme to activase was the most essential condition to optimize. The 
optimized ratio of enzyme to activase leads to the highest concentration of 
products with the least amount of completely digested protein. Having too much 
proteolytic activity leads to only very small protein fragments; not having enough 
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Table 1: Table of optimized digestion reaction, including: moles, concentrations, 
mass, and molar ratio of protein to proteolytic enzyme. 
 
The concentration of ADP was not as important as it was expected to be. 
Varying the amount of ADP did not have a noticeable effect on the digestion 
products based on SDS-PAGE results. By reducing the amount of ADP present in 
the digestion, fewer activase proteins should be bound to ADP. Activase not 
bound to ADP should be more flexible, allowing better access for the proteolytic 
enzyme to bind to the parts of activase that may be inaccessible while bound to 
ADP. This does not appear to be the case as can be seen in Figure 6. 
 
Moles                      
(1ml rxn) 
Molar 
Concentration      
(1ml rxn) 
Mass                  
(1ml rxn) 





16.8 nM 16.8 mΜ 625 μg 
Activase:Chymotrypsin 
233:1 
ADP 8.3 nM 8.3 mΜ 3.5 μg 










Activase:ADP                 
2.02:1 
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Figure 6: SDS-PAGE result of two different ADP concentration digestions 
via α-chymotrypsin over 120 min. Activase and α-chymotrypsin concentrations 
are held constant at 16.8 μM and 72 nM respectively. Lanes 2,4,5,6, and 7 are 0 
min, 30 min, 60 min, 90 min, and 120 min with 8.3 μM ADP. Lanes 9, 10, 11, 12, 
and 13 are 0 min, 30 min, 60 min, 90 min and 120 min with 28.3 μM ADP. Lanes 
1 and 8 are controls (only activase after 120 min). Lane 3 is the molecular weight 
marker. 
 
The samples of activase provided by Dr. Michael Salvucci contained 1 
mM ADP. In order to reduce the ADP level to less than a 1:1 ratio, a sample of 
activase was dialyzed against buffer with no ADP and subsequently digested. By 
looking at the gel above in Figure 6, it is apparent that no substantial amount of 
new protein fragments were created by reducing the amount of ADP from the 
digestion. It may be possible that activase has a very high affinity for ADP and 
that the dialysis did not remove sufficient amounts of ADP. Along the same lines, 
it is possible that if activase has a high affinity for ADP, then as the activase 
proteins that are bound to ADP are cleaved, they could lose their association with 
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ADP. This would create more available ADP for intact activase proteins to 
associate with. One way to fix this is to create a recombinant protein and purify it 
without ADP.  
 After digestion conditions were optimized, digestions were performed so 
that the fragments could be isolated and characterized. Isolation of fragments via 
RP-HPLC was unsuccessful. It seems as though most of the sample became 
aggregated and was removed by either the syringe filter or the column pre-filter. 
Several different volumes of digestion were injected. None of the injection 
volumes provided better results than another. Next, protein blotting was used to 
isolate the fragments. Numerous samples were cut out of the PVDF membrane 
with the protein blotted onto it and were given to the proteomics lab for N-
terminal sequencing. The lab was able to identify the N-terminal sequence on two 
of the samples. One fragment from an α-chymotrypsin (NKQENA) digest and one 
fragment from a trypsin digest (MGGTTQYTVN). The other samples were too 
dilute to receive accurate results. In an attempt to try and increase the amount of 
protein on the PVDF membrane, several digestions were performed with 
increased protein concentration and increased blotting time, although the 
concentrations of the fragments on the PVDF membrane could not be increased 
enough to be N-terminally sequenced. The minimum amount of protein required 
for sequencing is about 12 picomoles so the digestion products must not be very 
prominent. The mass, determined by MALDI-TOF, of the trypsin digest fragment 
was 19.78 kDa, and the mass of the α-chymotrypsin digest fragment was 16.71 
kDa. The fragment of protein identified from the trypsin digest was a 175 amino 
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acid fragment believed to consist of some of the αβα subdomain and most of the 
all α subdomain based on the homology model. The fragment of protein identified 
from the α-chymotrypsin digest was a 146 amino acid fragment, which again 
consisted of some of the αβα subdomain and most of the all α subdomain. 
While being able to identify two protein fragments using limited 
proteolysis was a good start, it does not look as though any more fragments will 
be able to be identified in the same manner. It is likely that the digestion products 
that we are interested in are intermediate products which are only around for a 
short period of time before they are digested into smaller protein fragments. 
3.1.4 NtAβ(182-383)  and NtAβ(216-383) 
 The two fragments NtAβ(182-383)  and NtAβ(216-383) were  successfully 
cloned into pET151/dTOPO. Expression of the NtAβ(182-383) fragment yielded no 
visible bands via SDS-PAGE correlating to a fragment of this size. Expression 
temperatures of 25°C, 30°C, and 37°C were tested, and no bands for this fragment 
were visible via SDS-PAGE with any of these temperatures. Expression of the 
NtAβ(216-383) fragment yielded a large amount of protein correlating to a fragment 
of this size. However, this large amount of protein was in a non-soluble fraction. 
While trying to purify and crystallize non-soluble protein fragments is an option, 
that course of action could be time consuming and there is nothing to suggest that 
this fragment will crystallize. 
3.2 Conclusion and Future Work 
 While limited proteolysis worked for the group that isolated the E. coli 
Lon protease all-α subdomain, it was not successful in this study to isolate 
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fragments of activase and crystallize them. Creating a recombinant protein based 
on the homology model worked well; however, often times the truncated proteins 
that are created are not very soluble. The next step towards the crystallization of 
activase is to design and express more truncated recombinant activase proteins. 
The recombinant proteins can be designed based on the newest published activase 
structures and protein stability prediction programs such as Expasy’s protein 
parameter tool or FoldIndex. The recombinant proteins’ thermal stability and 
secondary structure compositions will be used to help guide the protein design 
process.    
Once a stable, soluble recombinant protein is expressed, crystallization 
screens will need to be performed and crystallization conditions will need to be 
optimized. Once the crystallization conditions are optimized and protein crystals 
of suitable quality are produced, X-ray diffraction data will be collected. The 
phase problem may be solved with heavy atom soaks from isomorphous crystals 
or from selenomethionine substituted proteins. Then, using the electron density 
map, the structure of the recombinant protein can be computed.  
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